SCHEMBL17676019

SCHEMBL17676019

CCC1(CC)CC1(F)F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17676190 0.84
SCHEMBL14135446 0.82
SCHEMBL19300328 0.78
SCHEMBL22648650 0.74
SCHEMBL16934001 0.69
SCHEMBL14681223 0.69
SCHEMBL27394977 0.69
SCHEMBL23409380 0.67
SCHEMBL17369200 0.67
SCHEMBL17676188 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240239788-A1 SMALL MOLECULE INHIBITORS OF KRAS G12D MUTANT TAIHO PHARMACEUTICAL CO., LTD. (JP) 2024-07-18 US disclosed
WO-2023154766-A1 KRAS MODULATORS AND USES THEREOF QUANTA THERAPEUTICS, INC. (US) 2023-08-17 WO disclosed
EP-3630771-B1 5,6-FUSED-BICYCLIC COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF PARASITIC DISEASES NOVARTIS AG (CH) 2022-06-29 EP disclosed
US-9309191-B2 Amidine compound and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2016-04-12 US disclosed
US-9309191-B2 Amidine compound and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2016-04-12 US disclosed